April 13, 2013; Boston, MA USA; Boston Red Sox relief pitcher Joel Hanrahan (52) pitches during the ninth inning against the Tampa Bay Rays at Fenway Park. Mandatory Credit: Bob DeChiara-USA TODAY Sports

The Detroit Tigers Are Interested In Joel Hanrahan


For the second straight season the Tigers made offseason improvements to the bullpen. And for the second straight season it has been the biggest question mark.

This season the additions of Joe Nathan, Ian Krol and the return of Bruce Rondon were supposed to give the Tigers a solid options late in the ball game. But a season has not been kind to Detroit relievers.  So far the bullpen has suffered a season ending injury to Rondon, a dead arm on Joe Nathan, a sexual assault case against Evan Reed, a low start by Ian Krol and the complete implosion of Phil Coke. All of this has led the Tigers to look for options outside the organization.

Enter Joel Hanrahan the unsigned free agent who recently held a workout to prove he is recovered from off-season surgery to his pitching arm. The workout went well. So well in fact that Hanrahan could be mulling over several offers from team this evening including a possible offer from the Detroit Tigers according to Jon Heyman of CBS Sports.

The Tigers, Yankees, Rangers, Red Sox and Rockies are believed among teams showing strong interest in free-agent closer Joel Hanrahan, who is likely to sign before holding another open showcase. Hanrahan is believed to have received multiple offers, with at least those five teams thought to be in the running for the hard-throwing two-time All-Star.

It certainly makes sense for the Tigers to be i the running for Joel Hanrahan’s services considering the condition of the bullpen. Hanrahan has 100 career saves and is just two years removed from an all-star appearance as the pirates closer. If fully recovered from off-season surgery, signing Hanrahan would go along way to shoring up the Tigers embattled bullpen.

Dick's Sporting Goods presents "Hell Week":

Tags: Detroit Tigers Joel Hanrahan

Comments are closed.